Answer
Feb 13, 2026 - 09:57 AM
The bioavailability of dextromethorphan is increased because quinidine inhibits the enzyme CYP2D6, which would otherwise break it down. Enhanced bioavailability means more active drug is available in the body, improving symptom control.
